Clinical Trial Update: A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating serum-free Avonex versus Avonex-containing serum in healthy volunteers, sponsored by Biogen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED